Cargando…

Monkeypox Disease Outbreak (2022): Epidemiology, Challenges, and the Way Forward

The biggest-ever outbreak of monkeypox disease in non-endemic countries started in May, 2022. Though no monkeypox case has been reported from India, till mid-June, 2022, yet, considering the rate of spread to the non-endemic countries, there is an urgent need of better understanding of the monkeypox...

Descripción completa

Detalles Bibliográficos
Autores principales: Lahariya, Chandrakant, Thakur, Archana, Dudeja, Nonita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419123/
https://www.ncbi.nlm.nih.gov/pubmed/35762024
http://dx.doi.org/10.1007/s13312-022-2578-2
_version_ 1784777106882822144
author Lahariya, Chandrakant
Thakur, Archana
Dudeja, Nonita
author_facet Lahariya, Chandrakant
Thakur, Archana
Dudeja, Nonita
author_sort Lahariya, Chandrakant
collection PubMed
description The biggest-ever outbreak of monkeypox disease in non-endemic countries started in May, 2022. Though no monkeypox case has been reported from India, till mid-June, 2022, yet, considering the rate of spread to the non-endemic countries, there is an urgent need of better understanding of the monkeypox virus and disease epidemiology to help clinicians, public health specialists, and policymakers to be prepared for any eventuality. This review summarises the monkeypox disease epidemiology, clinical features, therapies, vaccines and outlines the measures for preparedness and response for a possible outbreak. The disease is known to cause severe outcome in children, pregnant women, and immunocompromised hosts and this group need to be given special attention. The monkeypox disease outbreak (2022) in non-endemic countries should be used as an opportunity by India and other low and middle income countries to strengthen public health surveillance and health system capacity for outbreak and epidemic preparedness and response. ELECTRONIC SUPPLEMENTARY MATERIAL: Supplementary material is available for this article at 10.1007/s13312-022-2578-2 and is accessible for authorized users.
format Online
Article
Text
id pubmed-9419123
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer India
record_format MEDLINE/PubMed
spelling pubmed-94191232022-08-30 Monkeypox Disease Outbreak (2022): Epidemiology, Challenges, and the Way Forward Lahariya, Chandrakant Thakur, Archana Dudeja, Nonita Indian Pediatr Review Article The biggest-ever outbreak of monkeypox disease in non-endemic countries started in May, 2022. Though no monkeypox case has been reported from India, till mid-June, 2022, yet, considering the rate of spread to the non-endemic countries, there is an urgent need of better understanding of the monkeypox virus and disease epidemiology to help clinicians, public health specialists, and policymakers to be prepared for any eventuality. This review summarises the monkeypox disease epidemiology, clinical features, therapies, vaccines and outlines the measures for preparedness and response for a possible outbreak. The disease is known to cause severe outcome in children, pregnant women, and immunocompromised hosts and this group need to be given special attention. The monkeypox disease outbreak (2022) in non-endemic countries should be used as an opportunity by India and other low and middle income countries to strengthen public health surveillance and health system capacity for outbreak and epidemic preparedness and response. ELECTRONIC SUPPLEMENTARY MATERIAL: Supplementary material is available for this article at 10.1007/s13312-022-2578-2 and is accessible for authorized users. Springer India 2022-06-27 2022 /pmc/articles/PMC9419123/ /pubmed/35762024 http://dx.doi.org/10.1007/s13312-022-2578-2 Text en © Indian Academy of Pediatrics 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review Article
Lahariya, Chandrakant
Thakur, Archana
Dudeja, Nonita
Monkeypox Disease Outbreak (2022): Epidemiology, Challenges, and the Way Forward
title Monkeypox Disease Outbreak (2022): Epidemiology, Challenges, and the Way Forward
title_full Monkeypox Disease Outbreak (2022): Epidemiology, Challenges, and the Way Forward
title_fullStr Monkeypox Disease Outbreak (2022): Epidemiology, Challenges, and the Way Forward
title_full_unstemmed Monkeypox Disease Outbreak (2022): Epidemiology, Challenges, and the Way Forward
title_short Monkeypox Disease Outbreak (2022): Epidemiology, Challenges, and the Way Forward
title_sort monkeypox disease outbreak (2022): epidemiology, challenges, and the way forward
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419123/
https://www.ncbi.nlm.nih.gov/pubmed/35762024
http://dx.doi.org/10.1007/s13312-022-2578-2
work_keys_str_mv AT lahariyachandrakant monkeypoxdiseaseoutbreak2022epidemiologychallengesandthewayforward
AT thakurarchana monkeypoxdiseaseoutbreak2022epidemiologychallengesandthewayforward
AT dudejanonita monkeypoxdiseaseoutbreak2022epidemiologychallengesandthewayforward